SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (24557)4/18/2001 4:45:24 PM
From: Jibacoa  Read Replies (1) | Respond to of 29382
 
<<My guess is that GNLB is an easy double this year from current prices.>>

You mean from the $1.37 level ?

If that's the case I would agree.<g>

Bernard



To: Amigo Mike who wrote (24557)4/24/2001 7:45:51 PM
From: Toni Wheeler  Respond to of 29382
 
Hey Amigo Mike,

RE: "GNLB took a nasty dip..."

You ain't kiddin' it did!!

But, hold up;

"Though the Risks Have Increased, 'Reports of Aslera's Death Were an Exaggeration.' Reiterating BUY on 60:40 Chance of Approval"

low and behold we have a recommendation [for the hardy bio-gamblers] and an analysis of the FDA Advisory Comm. meeting:

Message 15712192

Mebbe GNLB ain't dead yet! LOL

My best,
T.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News